Tokyo, Japan

Koichi Ozawa

This inventor holds 2 USPTO granted patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1998-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Koichi Ozawa. Retrieved from https://idiyas.com/inventor/koichi-ozawa-cx5swjqa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Koichi Ozawa

Introduction

Koichi Ozawa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his work on sucralfate preparations. With a total of 2 patents to his name, Ozawa continues to push the boundaries of innovation in his industry.

Latest Patents

Ozawa's latest patents include advancements in sucralfate preparations. His work focuses on melt granulated sucralfate preparations and the processes involved in their creation. These innovations are crucial for improving the efficacy and delivery of pharmaceutical treatments.

Career Highlights

Ozawa is currently employed at Chugai Pharmaceutical Co., Ltd., where he applies his expertise in developing new pharmaceutical formulations. His career has been marked by a commitment to enhancing patient care through innovative drug development.

Collaborations

Throughout his career, Ozawa has collaborated with talented individuals such as Koji Kashimura and Katsuya Matsuda. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.

Conclusion

Koichi Ozawa's contributions to the field of pharmaceuticals exemplify the spirit of innovation. His work on sucralfate preparations highlights the importance of continuous research and development in improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…